A system view and analysis of essential hypertension
暂无分享,去创建一个
[1] G. Heinze,et al. Proteomic-Biostatistic Integrated Approach for Finding the Underlying Molecular Determinants of Hypertension in Human Plasma , 2017, Hypertension.
[2] Jie Zheng,et al. An update on genome-wide association studies of hypertension , 2015, Applied Informatics.
[3] E. Schiff,et al. Factors that predict the development of hypertension in women with pregnancy induced hypertension , 2015 .
[4] A. Dominiczak,et al. Genetic and molecular aspects of hypertension. , 2015, Circulation research.
[5] S. Textor. Secondary hypertension: renovascular hypertension. , 2014, Journal of the American Society of Hypertension : JASH.
[6] F. Marques,et al. The emerging role of non-coding RNA in essential hypertension and blood pressure regulation , 2014, Journal of Human Hypertension.
[7] F. Liu,et al. Glucocorticoids Transcriptionally Regulate miR-27b Expression Promoting Body Fat Accumulation Via Suppressing the Browning of White Adipose Tissue , 2014, Diabetes.
[8] Youwen Liu,et al. miR-27 inhibits adipocyte differentiation via suppressing CREB expression. , 2014, Acta biochimica et biophysica Sinica.
[9] F. Messerli,et al. Secondary arterial hypertension: when, who, and how to screen? , 2014, European heart journal.
[10] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[11] Zhi-yuan Yu,et al. Sp1 trans-activates and is required for maximal aldosterone induction of the αENaC gene in collecting duct cells. , 2013, American journal of physiology. Renal physiology.
[12] Chang-gong Liu,et al. miRNA-548c: a specific signature in circulating PBMCs from dilated cardiomyopathy patients. , 2013, Journal of molecular and cellular cardiology.
[13] G. Vanpoucke,et al. Integrated Proteomics Pipeline Yields Novel Biomarkers for Predicting Preeclampsia , 2013, Hypertension.
[14] Jing Wang,et al. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013 , 2013, Nucleic Acids Res..
[15] J. Mehta,et al. MicroRNAs Involved in the Regulation of Postischemic Cardiac Fibrosis , 2013, Hypertension.
[16] Lei Deng,et al. PrePPI: a structure-informed database of protein–protein interactions , 2012, Nucleic Acids Res..
[17] Jun-ichi Satoh,et al. Molecular network analysis of human microRNA targetome: from cancers to Alzheimer’s disease , 2012, BioData Mining.
[18] D. Karolina,et al. Circulating miRNA profiles in patients with metabolic syndrome. , 2012, The Journal of clinical endocrinology and metabolism.
[19] I. McGonnell,et al. Expression of guanylyl cyclase-B (GC-B/NPR2) receptors in normal human fetal pituitaries and human pituitary adenomas implicates a role for C-type natriuretic peptide. , 2012, Endocrine-Related Cancer.
[20] P. Sethupathy,et al. Abstract 24: MicroRNA-27b Is a Regulatory Hub in Lipid Metabolism and Is Altered in Dyslipidemia , 2012, Arteriosclerosis, Thrombosis, and Vascular Biology.
[21] Andrea Knau,et al. MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. , 2012, Blood.
[22] T. Coffman,et al. Under pressure: the search for the essential mechanisms of hypertension , 2011, Nature Medicine.
[23] I. Maruyama,et al. Quantitative peptidomic analysis by a newly developed one‐step direct transfer technology without depletion of major blood proteins: Its potential utility for monitoring of pathophysiological status in pregnancy‐induced hypertension , 2011, Proteomics.
[24] E. Olson,et al. Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters , 2011, Proceedings of the National Academy of Sciences.
[25] Damian Szklarczyk,et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..
[26] Jesmin,et al. Gene regulatory network reveals oxidative stress as the underlying molecular mechanism of type 2 diabetes and hypertension , 2010, BMC Medical Genomics.
[27] Marcin Piechota,et al. Identification of cis-Regulatory Elements in the Mammalian Genome: The cREMaG Database , 2010, PloS one.
[28] Jean-Stéphane Varré,et al. TFM-Explorer: mining cis-regulatory regions in genomes , 2010, Nucleic Acids Res..
[29] C. Dani,et al. microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. , 2009, Biochemical and biophysical research communications.
[30] Kwang-Hyun Cho,et al. Hub genes with positive feedbacks function as master switches in developmental gene regulatory networks , 2009, Bioinform..
[31] Jianping Ye,et al. A role of miR‐27 in the regulation of adipogenesis , 2009, The FEBS journal.
[32] S. G. Lima,et al. Renin-angiotensin system: is it possible to identify hypertension susceptibility genes? , 2007, Arquivos brasileiros de cardiologia.
[33] Brad T. Sherman,et al. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists , 2007, Genome Biology.
[34] J. Saavedra. The challenge of genetic studies in hypertension. , 2007, Circulation research.
[35] M. Gerstein,et al. Getting connected: analysis and principles of biological networks. , 2007, Genes & development.
[36] I. King Jordan,et al. A Family of Human MicroRNA Genes from Miniature Inverted-Repeat Transposable Elements , 2007, PloS one.
[37] E. Porteri,et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. , 2006, Journal of the American College of Cardiology.
[38] A. Cowley. The genetic dissection of essential hypertension , 2006, Nature Reviews Genetics.
[39] P. Guyenet. The sympathetic control of blood pressure , 2006, Nature Reviews Neuroscience.
[40] Weihong Yan,et al. Expression-based monitoring of transcription factor activity: the TELiS database , 2005, Bioinform..
[41] D. Gardner,et al. Transcriptional Regulation of Type B Human Natriuretic Peptide Receptor Gene Promoter: Dependence on Sp1 , 2004, Hypertension.
[42] George Howard,et al. Insulin Resistance and Hypertension: The Insulin Resistance Atherosclerosis Study , 2004, Hypertension.
[43] N. Abate,et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. , 2004, Kidney international.
[44] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[45] P. Munroe,et al. Genes and hypertension. , 2003, Current pharmaceutical design.
[46] J. Sowers,et al. Interactive effects of insulin-like growth factor-1 and beta-estradiol on endothelial nitric oxide synthase activity in rat aortic endothelial cells. , 2003, Metabolism: clinical and experimental.
[47] M. Klagsbrun,et al. Characterization of the neuropilin‐1 promoter; gene expression is mediated by the transcription factor Sp1 , 2003, Journal of cellular biochemistry.
[48] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[49] F. Messerli,et al. Diabetes, hypertension, and cardiovascular disease: an update. , 2001, Hypertension.
[50] J. Sowers,et al. Vascular insulin/insulin-like growth factor-1 resistance in female obese Zucker rats. , 2001, Metabolism: clinical and experimental.
[51] M. Flesch,et al. On the trail of cardiac specific transcription factors. , 2001, Cardiovascular research.
[52] Q. Xu,et al. Sp1 Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular Endothelium , 2000, The Journal of Biological Chemistry.
[53] Albert,et al. Emergence of scaling in random networks , 1999, Science.
[54] G. Nickenig,et al. Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. , 1998, Circulation.
[55] K. Siddle,et al. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. , 1998, The Biochemical journal.
[56] J. Sowers,et al. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. , 1997, Hypertension.
[57] R. Muniyappa,et al. Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. , 1996, Endocrinology.
[58] G. Reaven,et al. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.
[59] M. Romo,et al. Hyperinsulinemia in Normotensive Offspring of Hypertensive Parents , 1994, Hypertension.
[60] A. Lever. Angiotensin II, angiotensin-converting enzyme inhibitors, and blood vessel structure. , 1992, The American journal of medicine.
[61] Richard Barnett. Diabetes , 1904, The Lancet.
[62] Andrew D. Johnson,et al. Integrative network analysis reveals molecular mechanisms of blood pressure regulation. , 2015, Molecular systems biology.
[63] Anton J. Enright,et al. Network visualization and analysis of gene expression data using BioLayout Express3D , 2009, Nature Protocols.
[64] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[65] Cynthia M. Lakon,et al. How Correlated Are Network Centrality Measures? , 2008, Connections.
[66] J. Hokanson,et al. The Insulin Resistance Atherosclerosis Study Family Study , 2004 .
[67] A. Baron,et al. Vascular reactivity. , 1999, The American journal of cardiology.